

Delcath Systems Information
Summary
Delcath Systems is a public company that has been in the industry for 37 years. The company currently specializes in the Pharmaceuticals area. The position of the CEO is occupied by Gerard Michel. Its headquarters is located at New York, New York, USA. The number of employees ranges from 25 to 100. The annual revenue of Delcath Systems varies between 100K and 5.0M. Total funding of the company - $58.3M. To connect with Delcath Systems employee register on SignalHire.
Industries
Pharmaceuticals
Headquarters Location
Employees Size
100-200 employees
Specialties
Oncology, Research & Development, Liver Cancers, Ocular Melanoma, Intrahepatic cholangiocarcinoma, Hepatocellular carcinoma, Uveal Melanoma, Metastatic Uveal Melanoma, Hepatic dominant uveal melanoma, Liver directed therapy
SIC Code
8000, 5047
DMA Code
New York Metropolitan Area
Founded
1987
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Independent Company
Contact Delcath Systems
Organization Website
Social Links
Phone Number
212-489-2100, 2124892102
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2007 | Public Company | 100 - 250 | 100.6M | $470.2M | |
1998 | Public Company | 1 - 25 | < 1M | $190M | |
2009 | Public Company | 1.0K - 5.0K | 45M | $634.9M | |
2010 | Privately Held | 25 - 100 | 13M | $1M | |
2004 | Privately Held | 1000-5000 | - | $- | |
2008 | - | 500-1000 | - | $- | |
- | - | 10-50 | - | $- |
Estimated Website Traffic
The chart shows a growth in traffic to the delcath.com website. In September, traffic increased to 5021, compared to 5013 in the previous month. The highest traffic in 2025 was recorded in September, reaching 5021 visits.